pubmed-article:1293187 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1293187 | lifeskim:mentions | umls-concept:C0023343 | lld:lifeskim |
pubmed-article:1293187 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:1293187 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
pubmed-article:1293187 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:1293187 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:1293187 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:1293187 | pubmed:dateCreated | 1993-4-7 | lld:pubmed |
pubmed-article:1293187 | pubmed:abstractText | A gelatin particle agglutination assay for the detection of anti PGL-I antibodies in 40 clinically diagnosed and variously classified groups of leprosy cases revealed elevated PGL-I antibody titers in 85% of cases. In contrast, the slit-skin smear examination was positive in only 30% of cases. It was further observed that, out of 28 cases with Bacteriological Index (B.I.) zero, 22 cases (78.5%) had significant levels of PGL-I antibodies. There was no case in which the slit skin smear was positive and the PGL-I antibody titer was not significant. The elevated titers of PGL-I antibody better correlated (84%) with histopathological findings than did B.I. Thus it was concluded that estimation of PGL-I antibody titer is a better supplement to clinical diagnosis than B.I. Significant levels of PGL-I antibody were seen in 85% of cases who had no earlier chemotherapy or were treated for less than 2 months. Similar findings were observed in 12 patients who were on MDT for more than 5 months but for less than 2 years. In order to determine the significance of anti PGL-I antibodies in monitoring the response of patients to chemotherapy, a longer follow up with a greater number of cases should be contemplated. | lld:pubmed |
pubmed-article:1293187 | pubmed:language | eng | lld:pubmed |
pubmed-article:1293187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1293187 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1293187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1293187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1293187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1293187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1293187 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1293187 | pubmed:month | Dec | lld:pubmed |
pubmed-article:1293187 | pubmed:issn | 0385-2407 | lld:pubmed |
pubmed-article:1293187 | pubmed:author | pubmed-author:SehgalV NVN | lld:pubmed |
pubmed-article:1293187 | pubmed:author | pubmed-author:PrakashKK | lld:pubmed |
pubmed-article:1293187 | pubmed:author | pubmed-author:AggarwalRR | lld:pubmed |
pubmed-article:1293187 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1293187 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:1293187 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1293187 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1293187 | pubmed:pagination | 953-8 | lld:pubmed |
pubmed-article:1293187 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:meshHeading | pubmed-meshheading:1293187-... | lld:pubmed |
pubmed-article:1293187 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1293187 | pubmed:articleTitle | Significance of antibodies to phenolic glycolipid-I in leprosy diagnosis. | lld:pubmed |
pubmed-article:1293187 | pubmed:affiliation | Department of Microbiology, Lady Hardinge Medical College, New Delhi, India. | lld:pubmed |
pubmed-article:1293187 | pubmed:publicationType | Journal Article | lld:pubmed |